References
- Grassmann A, Gioberge S, Moeller S, Brown G. End-stage renal disease: Global demographics in 2005 and observed trends. Artif Organs. 2006;30:895–897
- Wolcott DL, Wellisch DK, Marsh JT, Schaeffer J, Landsverk J, Nissenson AR. Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients. Am J Kidney Dis. 1988;12:275–284
- Shidler NR, Peterson RA, Kimmel PL. Quality of life and psychocial psychosocial relationships in patients with chronic renal insufficiency. Am J Kidney Dis. 1998;32:557–566
- Valderrabano F, Jofre R, Lopez-Gomez JM. Quality of life in endstage renal disease patients. Am J Kidney Dis. 2001;38:443–464
- Kimmel PL, Peterson RA, Weihs KL, et al. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis. J Am Soc Nephrol. 1996;7:2152–2159
- Kimmel PL, Weihs K, Peterson RA. Survival in hemodialysis patients: The role of depression. J Am Soc Nephrol. 1993;4:12–27
- Kimura H, Ozaki N. Diagnosis and treatment of depression in dialysis patients. Ther Apher Dial. 2006;10:328–332
- Israel M. Depression in dialysis patients: A review of psychological factors. Can J Psychiatry. 1986;31:445–451
- Furr LA. Psycho-social aspects of serious renal disease and dialysis: A review of the literature. Soc Work Health Care. 1998;27:97–118
- Ignacio ZM, Reus GZ, Abelaira HM, Quevedo J. Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: Insights in depression. Neuroscienc. 2014;275:455–468
- Sung CC, Hsu YC, Chen CC, Lin YF, Wu CC. Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease. Oxid Med Cell Longev. 2013;2013:301982
- Bautovich A, Katz I, Smith M, Loo CK, Harvey SB. Depression and chronic kidney disease: A review for clinicians. Aust N Z J Psychiatry. 2014;48:530–541
- Zoladz JA, Smigielski M, Majerczak J, et al. Hemodialysis decreases serum brain-derived neurotrophic factor concentration in humans. Neurochem Res. 2012;37:2715–2724
- Hisli N. Beck Depresyon Envanterinin geçerliği üzerine bir çalışma [A study on the validity of Beck Depression Inventory]. Psikoloji Dergisi. 1988;6:118–122
- Philpot J. Assay for MDA levels. Rad Res. 1963;3:55–80
- Ellman GL, Gan GL. Erythrocyte glutathione-levels in patients of a mental hospital. Nature. 1964;30:202–904
- Shin SJ, Yoon HE, Chung S, Kim YG, Kim DJ. Plasma brain-derived neurotrophic factor in hemodialysis patients. Int J Med Sci. 2012;9:772–777
- Shimada H, Park H, Makizako H, Doi T, Lee S, Suzuki T. Depressive symptoms and cognitive performance in older adults. J Psychiatr Res. 2014;57:149–156
- Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003;54:70–75
- Fernandes BS, Gama CS, Kauer- Sant'Anna M, Lobato MI, Belmonte-de-Abreu P, Kapczinski F. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: A potential adjunctive tool for differential diagnosis. J Psychiatr Res. 2009;43:1200–1204
- Haghighi M, Salehi I, Erfani P, et al. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only. J Psychiatr Res. 2013;47:908–915
- Moylan S, Berk M, Dean OM, et al. Oxidative & nitrosative stress in depression: Why so much stress? Neurosci Biobehav Rev. 2014;45:46–62
- Marques de Mattos A, Marino LV, Ovidio PP, Jordao AA, Almeida CC, Chiarello PG. Protein oxidative stress and dyslipidemia in dialysis patients. Ther Apher Dial. 2012;16:68–74
- Ahmadpoor P, Eftekhar E, Nourooz-Zadeh J, Servat H, Makhdoomi K, Ghafari A. Glutathione, glutathione-related enzymes, and total antioxidant capacity in patients on maintenance dialysis. Iran J Kidney Dis. 2009;3:22–27
- Puchades MJ, Saez G, Munoz MC, et al. Study of oxidative stress in patients with advanced renal disease and undergoing either hemodialysis or peritoneal dialysis. Clin Nephrol. 2013; 80:177–186
- Meenakshi SR, Agarwal RJ. Nitric oxide levels in patients with chronic renal disease. Clin Diagn Res. 2013;7:1288–1290
- Kovacevic P, Dragic S, Rajkovaca Z, Veljkovic S, Kovacevic T. Serum levels of nitric oxide and endothelin-1 in patients treated with continuous ambulatory peritoneal dialysis. Ren Fail. 2014;36:437–440
- Hacişevki A, Gönenç A, Sezer S, Karakan S, Simşek B, Torun M. Accumulation of an endogenous inhibitor of nitric oxide synthesis and oxidative DNA damage in end-stage renal disease. Clin Lab. 2013;59:1353–1361